Table 1.
Disease activity measure | |
1 |
Tender joint count |
2 |
Swollen joint count |
3 |
Patient’s assessment of pain |
4 |
Patient’s global assessment of disease activity |
5 |
Physician’s assessment of physical function |
6 |
Patient’s assessment of physical function |
7 |
Acute-phase reactant value |
For trial duration ≥1 year and agent being tested as a ‘DMARD’, also perform: | |
8 | Radiography or other imaging technique |
DMARD disease-modifying anti-rheumatic drug.